Literature DB >> 172805

cAMP as a second messenger in central blood pressure control.

A Walland.   

Abstract

Injections of dibutyryl cyclic adenosine 3',5'-monophosphate in doses of 125, 250 and 500 mug/kg into the lateral cerebral ventricle of anaesthetised cats produced dose dependent increases in blood pressure and heart rate, while doses of 50, 100 and 200 mug/kg imidazole-4-acetic acid, a stimulator of phosphodiesterase, exerted an opposite effect. The results are discussed in the light of the hypothesis that the activity of cardiovascular centres is determined by their concentration of cyclic AMP.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 172805     DOI: 10.1007/bf00499953

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  12 in total

1.  Stimulation of sympathetic centers by histamine.

Authors:  U TRENDELENBURG
Journal:  Circ Res       Date:  1957-01       Impact factor: 17.367

Review 2.  The positive inotropic effect of cyclic AMP.

Authors:  W R Kukovetz; G Pöch
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

Review 3.  On the regulation of adenyl cyclase activity in the rat pineal gland.

Authors:  B Weiss
Journal:  Ann N Y Acad Sci       Date:  1971-12-30       Impact factor: 5.691

4.  Histamine H2 receptors and cyclic AMP in brain.

Authors:  S R Nahorski; K J Rogers; B M Smith
Journal:  Life Sci       Date:  1974-12-01       Impact factor: 5.037

5.  Central beta-adrenoceptor sites and ouabain action.

Authors:  P R Saxena; K P Bhargava
Journal:  Pharmacol Res Commun       Date:  1974-08

6.  Some properties of cyclic 3',5'-nucleotide phosphodiesterase of mouse brain: effects of imidazole-4-acetic acid, chlorpromazine, cyclic 3',5'-GMP, and other substances.

Authors:  E Roberts; D G Simonsen
Journal:  Brain Res       Date:  1970-11-11       Impact factor: 3.252

7.  Comparative studies on central factors contributing to the hypotensive action of propranolol, alprenolol, and their enantiomers.

Authors:  L Offerhaus; P A van Zwieten
Journal:  Cardiovasc Res       Date:  1974-07       Impact factor: 10.787

8.  Central alpha- and beta-adrenoceptors modifying arterial blood pressure and heart rate in conscious cats.

Authors:  M D Day; A G Roach
Journal:  Br J Pharmacol       Date:  1974-07       Impact factor: 8.739

Review 9.  Metabolism and functions of cyclic AMP in nerve.

Authors:  G I Drummond
Journal:  Prog Neurobiol       Date:  1973       Impact factor: 11.685

10.  Comparison of the effects of biogenic amines on cyclic GMP and cycle AMP levels in mouse cerebellum in vitro.

Authors:  J A Ferrendelli; D A Kinscherf; M M Chang; J F Morgan
Journal:  Brain Res       Date:  1975-01-24       Impact factor: 3.252

View more
  7 in total

1.  Central hypotensive effects of imidazole acetic acid and rolipram (ZK 62 711) in rats [proceedings].

Authors:  H Karppanen; P Paakkari; A L Orma; I Paakkari
Journal:  Agents Actions       Date:  1979-04

2.  Cyclic nucleotides and central cardiovascular control in the cat [proceedings].

Authors:  P J Clipsham; T C Hamilton; A E Hunt; R H Poyser
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

3.  Decreased cAMP content of the hypothalamus of genetically hypertensive rats.

Authors:  G Schmid; K Hempel; A Heidland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

4.  Further evidence for the involvement of cAMP in central blood pressure regulation.

Authors:  A Walland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-01       Impact factor: 3.000

5.  Altered cyclic AMP levels in specific cardiovascular brain centers of spontaneously hypertensive rats (SHR).

Authors:  G Schmid; M Palkovits; U Bahner; A Heidland
Journal:  Klin Wochenschr       Date:  1980-10-01

6.  Central blood pressure effects of guanylyl-imido-diphosphate and cyclic guanosine-monophosphate.

Authors:  P Schuhmacher; A Walland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-05       Impact factor: 3.000

7.  Organic and Peptidyl Constituents of Snake Venoms: The Picture Is Vastly More Complex Than We Imagined.

Authors:  Alejandro Villar-Briones; Steven D Aird
Journal:  Toxins (Basel)       Date:  2018-09-26       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.